Evidence map›Paper›PMID 37525583›Full record

ArticleChembiochem : a European journal of chemical biology2023

Garcinolic Acid Distinguishes Between GACKIX Domains and Modulates Interaction Networks.

Meghan E Breen, Stephen T Joy, Omari J Baruti, Matthew S Beyersdorf, Madeleine J Henley, Samantha N De Salle, Peter D Ycas, Ayza Croskey, Tomasz Cierpicki, William C K Pomerantz and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Meghan E BreenLife Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.ORCID 0000-0003-1568-8533
Stephen T JoyLife Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.ORCID 0000-0002-6030-7835
Omari J BarutiProgram in Chemical Biology, Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.
Matthew S BeyersdorfProgram in Chemical Biology, Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.
Madeleine J HenleyProgram in Chemical Biology, Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.ORCID 0000-0002-0709-6186
Samantha N De SalleProgram in Chemical Biology, Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.
Peter D YcasDepartment of Chemistry, University of Minnesota, 207 Pleasant St SE, Minneapolis, MN-55455, USA.
Ayza CroskeyProgram in Chemical Biology, Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.ORCID 0000-0002-0806-0097
Tomasz CierpickiDepartment of Pathology, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.ORCID 0000-0003-2058-0658
William C K PomerantzDepartment of Chemistry, University of Minnesota, 207 Pleasant St SE, Minneapolis, MN-55455, USA.ORCID 0000-0002-0163-4078
Anna K MappDepartment of Chemistry and Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI-48109, USA.ORCID 0000-0003-0791-8327
Washtenaw Community College · USUniversity of Minnesota · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Michigan Chemistry-Biology Interface Training ProgramT32GM132046 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Emily E Scott, Wenjing Wang · 2019 to 2026
$4.1M
Probing transcriptional activation at the molecular level - Equipment SupplementR35GM136356 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANNA K. MAPP · 2020 to 2026
$3.3M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA046592NIGMS NIH HHS R35 GM136356NIGMS NIH HHS T32 GM132046NIH HHS CA242018NIH HHS GM136356NIH HHS NIH-P30CA046592NIH HHS T32 GM132046
6 · The paper itself

Abstract

Natural products are often uniquely suited to modulate protein-protein interactions (PPIs) due to their architectural and functional group complexity relative to synthetic molecules. Here we demonstrate that the natural product garcinolic acid allosterically blocks the CBP/p300 KIX PPI network and displays excellent selectivity over related GACKIX motifs. It does so via a strong interaction (K

Indexed as

CREB-Binding ProteinBinding SitesProtein BindingProtein DomainsProtein Structure, TertiaryCREB-Binding Proteinacute myelogenous leukemiaCBP/p300cMybnatural productprotein-protein interaction inhibitor

Identifiers

PMID37525583
PMCPMC10870240
OpenAlexW4385442244

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.